Drugs & TargetsFree Cellectar Biosciences Inc. receives second-phase of NCI SBIR award August 05, 2016Vol.42 No.31
Drugs & TargetsFree Advanced Accelerator Applications and NCI form clinical trial agreement August 05, 2016Vol.42 No.31
Drugs & TargetsFree FDA and CMS to undergo parallel review of FoundationOne genomic assay August 05, 2016Vol.42 No.31
Drugs & TargetsFree FDA Grants Breakthrough Therapy Designation to LEE011 in Metastatic Breast Cancer August 05, 2016Vol.42 No.31
FreeIn Brief Community Oncology Alliance launches Advanced Practice Provider Network August 05, 2016Vol.42 No.31
FreeIn Brief Vanderbilt-Ingram receives $3 million grant from Kleberg Foundation August 05, 2016Vol.42 No.31
FreeIn Brief UT Southwestern Kidney Cancer Program Receives $11 Million NCI SPORE Grant August 05, 2016Vol.42 No.31
FreeIn Brief Natascia Marino named Breast Cancer Research Foundation Investigator at Indiana University August 05, 2016Vol.42 No.31
FreeIn Brief Pierre Massion to direct Vanderbilt-Ingram’s early detection initiative August 05, 2016Vol.42 No.31
